|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| C07K 14/47 | (2006.01) |
| (11) | Patento numeris | 2565201 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12172030.4 |
| Europos patento paraiškos padavimo data | 2006-10-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 726608 P | 2005-10-17 | US | |
| 728304 P | 2005-10-20 | US |
| (72) |
Scheinberg, David A., US
Pinilla-Ibarz, Javier, US
May, Rena, US
|
| (73) |
Sloan-Kettering Institute for Cancer Research,
1275 York Avenue, New York, New York 10021,
US
|
| (54) | WT1 HLA class II-binding peptides and compositions and methods comprising same |
| WT1 HLA class II-binding peptides and compositions and methods comprising same |